Exagen (XGN) Non Operating Income (2022 - 2024)
Exagen's (XGN) quarterly Non Operating Income came in at $192000.0 in Q1 2024, down 70.73% YoY from $656000.0 in Q2 2023, and down 70.73% on a QoQ basis from $656000.0 in Q1 2023.
Exagen (XGN) Non Operating Income (2022 - 2024) Analysis & Trends
Exagen (XGN) has 3 years of Non Operating Income data on file, last reported at $192000.0 in Q1 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Op. Inc. (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 213.78 Bn | 209.71 Bn | 8.34 Bn | - |
| 2 | Danaher | 139.83 Bn | 135.48 Bn | 3.61 Bn | - |
| 3 | Idexx Laboratories | 45.99 Bn | 45.79 Bn | 779.09 Mn | - |
| 4 | Agilent Technologies | 39.69 Bn | 37.88 Bn | 990.00 Mn | - |
| 5 | Iqvia Holdings | 39.31 Bn | 37.23 Bn | 1.44 Bn | - |
| 6 | Natera | 38.74 Bn | 37.64 Bn | 696.04 Mn | - |
| 7 | Illumina | 29.94 Bn | 28.77 Bn | 770.00 Mn | 15.00 Mn |
| 8 | Mettler Toledo International | 28.55 Bn | 28.50 Bn | 650.22 Mn | - |
| 9 | Quest Diagnostics | 26.18 Bn | 25.55 Bn | 1.03 Bn | -63.00 Mn |
| 10 | Exagen | 158.04 Mn | 133.44 Mn | 12.22 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2024 | 192,000.00 |
| Mar 31, 2023 | 656,000.00 |
| Mar 31, 2022 | 5,000.00 |